Fidelity Disruptive Medicine ETF Rating $25.21 +0.03 (+0.12%) (As of 11:15 AM ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Fidelity Disruptive Medicine ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FMED Aggregate RatingModerate Buy 2.76Holdings in FMED have an aggregate rating of Moderate Buy based on 684 analyst ratings issued in the past year covering 45 companies (88.8% of the portfolio).FMED Aggregate Price Target$25.18-0.12% DownsideHigh Prediction$25.18Average Prediction$25.18Low Prediction$25.18Holdings in FMED have an aggregate price target of $25.18 and a range of $25.18 to $25.18 covering 45 companies (88.8% of the portfolio).FMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy32 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Fidelity Disruptive Medicine ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 45 FMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.99%BSXBoston Scientific$91.41+1.4%4.6004 of 5 stars2.91$93.39 2.2%23Analyst Forecast4.41%UNHUnitedHealth Group$600.01-0.1%4.9212 of 5 stars2.95$615.53 2.6%22Analyst DowngradeAnalyst RevisionPositive News4.27%ISRGIntuitive Surgical$547.05+1.0%4.6574 of 5 stars2.68$524.61 -4.1%19Analyst UpgradePositive News3.86%DHRDanaher$231.30-0.8%4.937 of 5 stars2.74$287.16 24.1%19Analyst DowngradePositive News3.85%PODDInsulet$263.62-1.1%4.3999 of 5 stars2.80$253.27 -3.9%15Positive News3.82%EXASExact Sciences$53.43+1.4%4.8873 of 5 stars2.95$74.47 39.4%19Analyst ForecastPositive News3.78%REGNRegeneron Pharmaceuticals$743.45+0.0%4.8024 of 5 stars2.78$1,099.55 47.9%23Positive News3.12%ALNYAlnylam Pharmaceuticals$249.89+0.4%4.3981 of 5 stars2.71$298.09 19.3%24Analyst Forecast3.04%ARGXargenx$588.56-0.6%2.8276 of 5 stars2.91$630.42 7.1%23Analyst Forecast2.58%SYKStryker$388.08+0.6%4.9421 of 5 stars2.80$393.65 1.4%20Analyst RevisionPositive News2.39%PENPenumbra$238.32-0.4%4.3239 of 5 stars2.71$227.92 -4.4%14Analyst ForecastInsider Trade2.30%LFSTLifeStance Health Group$7.24+0.3%1.7849 of 5 stars2.20$8.50 17.4%52.21%LEGNLegend Biotech$39.92-0.5%1.7671 of 5 stars3.00$81.46 104.1%13Analyst Revision2.09%INSPInspire Medical Systems$186.65+1.0%4.9104 of 5 stars2.75$233.58 25.1%12Analyst UpgradePositive News2.03%EWEdwards Lifesciences$70.05+0.7%4.1404 of 5 stars2.38$75.67 8.0%26Short Interest ↓Analyst Revision2.03%VEEVVeeva Systems$213.46+1.3%4.7509 of 5 stars2.58$236.92 11.0%24Analyst Forecast1.92%TMOThermo Fisher Scientific$509.72-0.6%4.9906 of 5 stars2.86$649.33 27.4%22Buyback AnnouncementPositive News1.90%AGLagilon health$1.73+3.3%2.2561 of 5 stars1.95$6.05 250.7%20Analyst Forecast1.88%LLYEli Lilly and Company$740.17-1.8%4.9913 of 5 stars2.81$1,007.94 36.2%21Analyst Revision1.88%DXCMDexCom$74.22-1.4%4.9841 of 5 stars2.72$104.59 40.9%18Positive News1.80%MASIMasimo$167.38+1.5%4.0735 of 5 stars2.71$163.67 -2.2%71.68%PRCTPROCEPT BioRobotics$94.10+1.5%1.5867 of 5 stars2.83$89.50 -4.9%61.67%WAYWaystar$30.68-0.8%2.2496 of 5 stars3.00$31.90 4.0%111.61%ZLABZai Lab$25.79-1.7%2.9675 of 5 stars3.00$52.50 103.6%4Analyst Revision1.44%JANXJanux Therapeutics$47.44-3.1%3.5987 of 5 stars2.90$66.44 40.1%101.39%GKOSGlaukos$143.90+1.7%3.8528 of 5 stars2.73$134.55 -6.5%11Positive News1.35%RMDResMed$242.03+0.2%4.7999 of 5 stars2.50$225.70 -6.7%12Positive News1.28%KROSKeros Therapeutics$54.25+0.2%3.4913 of 5 stars3.00$88.89 63.9%121.26%PCVXVaxcyte$87.22+1.5%3.2938 of 5 stars3.00$147.50 69.1%71.23%RGENRepligen$138.99+0.1%4.6306 of 5 stars2.73$190.25 36.9%11Gap Up1.18%XENEXenon Pharmaceuticals$40.06+1.8%3.4958 of 5 stars3.08$57.45 43.4%12Analyst Revision1.18%BRKRBruker$54.58+2.3%4.9986 of 5 stars2.55$79.36 45.4%11Dividend AnnouncementInsider Trade1.17%CRNXCrinetics Pharmaceuticals$55.87-0.4%3.5524 of 5 stars2.91$70.18 25.6%11Analyst Revision1.16%PRVAPrivia Health Group$20.76-0.1%3.3531 of 5 stars3.00$25.07 20.7%16Positive News1.11%TNDMTandem Diabetes Care$31.84+5.6%4.7632 of 5 stars2.78$54.25 70.4%18Positive News1.10%CYTKCytokinetics$49.35-1.0%4.0477 of 5 stars2.75$83.93 70.1%16Analyst ForecastInsider TradeOptions VolumeNews Coverage1.06%CNCCentene$59.30+0.3%4.9487 of 5 stars2.50$83.92 41.5%14Analyst Revision0.98%DYNDyne Therapeutics$29.97-0.1%3.3831 of 5 stars3.00$51.40 71.5%10Insider TradeAnalyst Revision0.93%WSTWest Pharmaceutical Services$314.56+0.9%4.9689 of 5 stars2.67$460.33 46.3%3Analyst Revision0.92%DOCSDoximity$48.94-1.9%3.0942 of 5 stars2.44$52.27 6.8%180.87%ASNDAscendis Pharma A/S$124.20-0.1%3.0193 of 5 stars2.92$191.77 54.4%13Analyst Upgrade0.83%PHRPhreesia$18.58+0.3%4.5853 of 5 stars2.92$29.42 58.3%12Positive News0.82%VRTXVertex Pharmaceuticals$447.70-0.8%4.0527 of 5 stars2.53$499.12 11.5%30Analyst DowngradeNews CoveragePositive News0.71%ALGNAlign Technology$226.55+1.2%4.7244 of 5 stars2.40$276.38 22.0%10Positive News0.70%TXG10x Genomics$13.11-1.6%4.694 of 5 stars2.53$29.19 122.6%17 This page (NASDAQ:FMED) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FMED Stock Alerts